As a consequence, using the age-specific PSA reference ranges proposed by Oesterling et al. for screening of prostate cancer in Taiwan might result in errors by increasing sensitivity and decreasing specificity in patients over 60 years old. The gene discussed is KLK3; the disease is Familial prostate cancer.